RxDoctor Payments Data

William Billett, MD

Psychiatry · Mobile, ALNPI 1306848254

Payments from drug & device makers

$2,626in general payments, 2019–2025

Across 38 payments — averaging $69.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$1K
  • Medtronic$751
  • Alkermes, Inc.$382
  • Johnson & Johnson$87
  • Neurocrine Biosciences, Inc.$72
  • Vanda Pharmaceuticals Inc.$34
  • plus $13 from 1 others

What the payments were for

  • Speaking & faculty fees$1,14143%
  • Travel & lodging$73928%
  • Food & beverage$74528%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,626 in reported general payments places this provider in the 70th percentile of 400 psychiatry providers in Alabama.

See all psychiatry providers in Alabama

Medicare billing

Part B allowed, 2024
$7,387
Medicare patients
31
Services billed
115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate18$49,914
Oxcarbazepine11$555
Trazodone Hcl44$402
Mirtazapine28$400
Divalproex Sodium ErDivalproex Sodium17$396
Aripiprazole15$305
Benztropine Mesylate23$283
Venlafaxine Hcl ErVenlafaxine Hcl20$277
Duloxetine Hcl16$227
Buspirone Hcl15$203
Olanzapine13$176
Quetiapine Fumarate16$146
Risperidone15$135
Paroxetine Hcl11$107
Fluoxetine Hcl16$102

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$87$49,91418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 400 psychiatry providers in Alabama.

Other psychiatry in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →